CAS: 171099-57-3 - Oritavancin

Formule : C₈₆H₉₇Cl₃N₁₀O₂₆

InChI : InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1

Code InChI : InChIKey=VHFGEBVPHAGQPI-LXKZPTCJSA-N

SMILES : O=C(O)C1NC(=O)C2NC(=O)C(NC(=O)C3NC(=O)C(NC(=O)C(NC(=O)C(NC)CC(C)C)C(O)C4=CC=C(OC=5C=C3C=C(OC6=CC=C(C=C6Cl)C2OC7OC(C)C(O)C(N)(C)C7)C5OC8OC(CO)C(O)C(O)C8OC9OC(C)C(O)C(NCC%10=CC=C(C=C%10)C%11=CC=C(Cl)C=C%11)(C)C9)C(Cl)=C4)CC(=O)N)C%12=CC=C(O)C(=C%12)C%13=C(O)C=C(O)C=C%131

Synonymes :

• (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-(4'-chloro[1,1'-biphenyl]-4-ylmethyl)vancomycin
• Ly-333328
• Orbactiv
• Oritavancin
• Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-<span class="text-smallcaps">L</span>-arabino-hexopyranosyl)-N^3′′-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-
• Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-arabino-hexopyranosyl)-N3′′-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-

ORITAVANCIN

CAS : 171099-57-3

• Formule : C₈₅H₉₄Cl₃N₉O₂₅
• Degré de pureté : 99%
• Masse moléculaire : 1748.0602

Oritavancin(LY-333328)

CAS : 171099-57-3

Oritavancin, a semisynthetic antibiotic for skin infections, approved by FDA on August 6, 2014, targets …

• Formule : C₈₆H₉₇Cl₃N₁₀O₂₆
• Couleur et forme : Liquid
• Masse moléculaire : 1793.12

Oritavancin

CAS : 171099-57-3

• Formule : C₈₆H₉₇Cl₃N₁₀O₂₆
• Masse moléculaire : 1793.12

Oritavancin

CAS : 171099-57-3

Oritavancin is a semi-synthetic lipoglycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to …

• Formule : C₈₆H₉₇Cl₃N₁₀O₂₆
• Degré de pureté : Min. 95%
• Couleur et forme : Powder
• Masse moléculaire : 1,793.1 g/mol